![PDF) Fragment-Based Cocktail Crystallography by the Medical Structural Genomics of Pathogenic Protozoa Consortium PDF) Fragment-Based Cocktail Crystallography by the Medical Structural Genomics of Pathogenic Protozoa Consortium](https://i1.rgstatic.net/publication/40023298_Fragment-Based_Cocktail_Crystallography_by_the_Medical_Structural_Genomics_of_Pathogenic_Protozoa_Consortium/links/004635212e1e3ddf23000000/largepreview.png)
PDF) Fragment-Based Cocktail Crystallography by the Medical Structural Genomics of Pathogenic Protozoa Consortium
Embryonic Stem Cell-Derived Hematopoietic Stem Cells: Challenges in Development, Differentiation, and Immunogenicity.
![PDF) Anti-Inflammatory and Antioxidant Properties of Piper Species: A Perspective from Screening to Molecular Mechanisms PDF) Anti-Inflammatory and Antioxidant Properties of Piper Species: A Perspective from Screening to Molecular Mechanisms](https://i1.rgstatic.net/publication/272518146_Anti-Inflammatory_and_Antioxidant_Properties_of_Piper_Species_A_Perspective_from_Screening_to_Molecular_Mechanisms/links/5db6de20299bf111d4d527a8/largepreview.png)
PDF) Anti-Inflammatory and Antioxidant Properties of Piper Species: A Perspective from Screening to Molecular Mechanisms
![Molecules | Free Full-Text | Identification of 3-Methoxycarpachromene and Masticadienonic Acid as New Target Inhibitors against Trypanothione Reductase from Leishmania Infantum Using Molecular Docking and ADMET Prediction Molecules | Free Full-Text | Identification of 3-Methoxycarpachromene and Masticadienonic Acid as New Target Inhibitors against Trypanothione Reductase from Leishmania Infantum Using Molecular Docking and ADMET Prediction](https://www.mdpi.com/molecules/molecules-26-03335/article_deploy/html/images/molecules-26-03335-g001-550.jpg)
Molecules | Free Full-Text | Identification of 3-Methoxycarpachromene and Masticadienonic Acid as New Target Inhibitors against Trypanothione Reductase from Leishmania Infantum Using Molecular Docking and ADMET Prediction
The influence of drug-like concepts on decision-making in medicinal chemistry - Document - Gale Academic OneFile
![Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS. - Abstract - Europe PMC Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5598487/bin/nihms903698f34.jpg)
Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS. - Abstract - Europe PMC
![Chemistry Congress Scientific Program | Medicinal Chemistry 2017 | Milan | Italy | Conferenceseries LLC Conferences Chemistry Congress Scientific Program | Medicinal Chemistry 2017 | Milan | Italy | Conferenceseries LLC Conferences](https://d2cax41o7ahm5l.cloudfront.net/cs/upload-images/medchempharma2017-11906.png)
Chemistry Congress Scientific Program | Medicinal Chemistry 2017 | Milan | Italy | Conferenceseries LLC Conferences
![Evidence-Based and Quantitative Prioritization of Tool Compounds in Phenotypic Drug Discovery: Cell Chemical Biology Evidence-Based and Quantitative Prioritization of Tool Compounds in Phenotypic Drug Discovery: Cell Chemical Biology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/fd0fde65-c489-4772-a34c-d94fe1135f0b/gr2.jpg)
Evidence-Based and Quantitative Prioritization of Tool Compounds in Phenotypic Drug Discovery: Cell Chemical Biology
Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone? | Journal of Medicinal Chemistry
![PDF) A Rapid, Large-Scale Synthesis of a Potent Cholecystokinin (CCK) 1R Receptor Agonist | Guy Humphrey - Academia.edu PDF) A Rapid, Large-Scale Synthesis of a Potent Cholecystokinin (CCK) 1R Receptor Agonist | Guy Humphrey - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/53160678/mini_magick20190121-10070-1poyxts.png?1548143603)